Replies to post #2751 on Biomoda Inc. (fka BMODQ)

[The Rainmaker]

When results were delayed last October we got our capitulation and flushed out many.....floats held by people who see the huge potential here.

Such a simple series of concepts involved here

1)There is no FDA approved inexpensive cancer screening test
2)Government Funded Cancer Screening alone is estimated to be a $1 billion dollar plus market.
3)BMOD's Cypath earlier tests showed near 100% accuracy in cancer detection
4)The Phase II Pilot Study Top line results coming out this month will validate Cypath technology in an FDA approved setting for the first time.
5)Health Insurance reimbursement codes are in place to pay for Cypath testing.
6)Cypath test costs between $100-$200
7)Early Cancer detection would save health insurers billions per year.
8) BMOD has publicly stated completed Phase II test results are good and they are moving on to final Pivotal Phase III testing based on these results.
9)When Phase II results are released this month it will open up a series of deals BMOD has been putting into place in preparation for this day.
10)This stocks price will most likely be revalued, much, much higher as soon the markets see those PII results and realize this is the golden lottery ticket they have all been searching for.